Atıf Formatları
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Artac Et Al. , "Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study," ANNALS OF ONCOLOGY , vol.33, 2022

Artac, M. Et Al. 2022. Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study. ANNALS OF ONCOLOGY , vol.33 .

Artac, M., Cubukcu, E., Bozkurt, O., Bilici, A., Celik, S., Ozcelik, M., ... Oven, B.(2022). Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study. ANNALS OF ONCOLOGY , vol.33.

Artac, M. Et Al. "Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study," ANNALS OF ONCOLOGY , vol.33, 2022

Artac, M. Et Al. "Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study." ANNALS OF ONCOLOGY , vol.33, 2022

Artac, M. Et Al. (2022) . "Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study." ANNALS OF ONCOLOGY , vol.33.

@article{article, author={M. Artac Et Al. }, title={Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study}, journal={ANNALS OF ONCOLOGY}, year=2022}